Serum Institute of India: Covishield (Oxford/ AstraZeneca formulation)

Vaccine Type: Non Replicating Viral Vector

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 2 Trials

Phase 3: 4 Trials

Approvals

Africa Regulatory Taskforce Endorsed

Caribbean Regulatory System Emergency Use Recommendation

WHO Emergency Use Listing

49 Countries

This vaccine is the same formulation as the Oxford/AstraZeneca vaccine (AZD1222)

Registered Trials